ban-icon

From Strength to Strength

Growing steadily in scale and reach

  • Nirma Limited acquired majority stake in Glenmark Life Sciences
  • Company name changed to Alivus Life Sciences
2024
  • Dahej Manufacturing facility gets ANVISA GMP certified
2022
  • Achieved milestone of 403 cumulative drug master files (DMFs) across multiple markets globally
  • Gets listed on Indian Stock Exchanges
2021
  • The API business was spun off into Glenmark Life Sciences
  • Ankleshwar plant inspected by US FDA, Health Canada and PMDA, Japan
2019
  • Dahej plant inspected by EDQM, ANSM and US FDA*
  • Mohol plant inspected by US FDA*

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2018
  • Dahej plant inspected by PMDA Japan

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2016
  • Dahej plant inspected by US FDA

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2015
  • Commenced manufacturing at Dahej, Gujarat*
  • Ankleshwar plant inspected by COFEPRIS*

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2013
  • Ankleshwar plant inspected by PMDA and AFSSAPS

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2012
  • Ankleshwar plant at Gujarat inspected by US FDA*

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2008
  • Commenced manufacturing at Mohol, Maharashtra*

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2004
  • First product registered with US FDA*
  • Acquired Glaxo SmithKline’s (GSK) API manufacturing plant in Ankleshwar, Gujarat *

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2003
  • Established manufacturing plant at Kurkumbh, Maharashtra*

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2002
  • Glenmark Pharmaceuticals established its API business *

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2001
world

Understand how we comply with the requirements of regulatory agencies around the world